Uncategorized
This Medford Clinic Is Developing a Coronavirus Vaccine, and You Wouldn’t Even Know It
Since July, the institute has been one of the staging grounds for a quest to find a vaccine for the novel coronavirus, which causes a disease that has killed more than 700 people in Oregon, more than 230,000 in the US, and 1.2 million worldwide. And inside, Gregg Lucksinger, the interim medical director of the institute, taps a business card against an oval wooden table in a brightly lit corner room. He leans back in an office chair and reminisces about the lessons learned in Liberia, where he worked in an Ebola treatment unit in 2015. He hopes those lessons will aide him and his colleagues now.
“In [Liberia], the epidemic overwhelmed health systems…. It was really fascinating to see that,” he says. “And that’s what we’re struggling with in the United States to prevent from happening. We’ve been really on the edge in a few places.”
Lucksinger’s work in clinical research began in Austin, Texas, during the HIV epidemic of the 1980s. He went on to help develop vaccines and/or therapeutics for HIV, hepatitis C, and Ebola.
Now, another complicated and highly contagious virus threatens humanity. Lucksinger and the institute in Oregon are working on two Phase 3 COVID-19 vaccine trials. The first, produced by biotech startup Moderna (which has been proven to reduce the risk of COVID-19 infection by 94.5 percent), has wrapped up its enrollment period and moved to data collection, a process by which research coordinators follow up with volunteers to see if they’ve developed symptoms of or contract the coronavirus as they go about their daily lives. This stage could take a year or two. The second trial is for a vaccine produced by Novavax. Under the White House’s Operation Warp Speed (OWS), a $10 billion initiative, COVID-19 vaccine and therapeutic trials have been accelerated, compressing what typically takes years into months. By running various processes in parallel and increasing the number of volunteers from a couple hundred to at least 30,000 for each trial, OWS hopes to have a vaccine by early 2021.
-
Crime & Safety4 days agoMan who told poIice that his famiIy member ‘wiII never do that again’ after consuming aIcohoI to gather the courage to kiII the older man at his home, then cIaimed the victim was polsoning him, was sentenced
-
Eugene1 week agoEugene firefighters contain garage fire on Sarah Lane
-
Crime & Safety5 days agoMom who cIaimed she took her 1-year-oId with her and that the baby was iII before she stopped breathing, Iater died, after Ieaving the chiId for hours in her vehicIe and never returned to check on her while she was cIeaning the residence, was sentenced
-
Eugene1 week agoEugene firefighters respond to structure fire in University District
-
Crime & Safety6 days agoMom cIaims she ‘Iost it’ when her 6-year-old disabIed chiId began sIamming his head on the fIoor and became vioIent before she pressed her hands on his throat as hard as she could and continued untiI he became Iifeless: police
-
Eugene1 week agoEugene Police report downtown congestion cleared after large march
-
Crime & Safety12 hours agoMan who created severaI Iarge hoIes in the waIIs of the home after admitting to deaIing repeated bIows to his spouse and repeatedIy kicking her while she was Iying on the fIoor for an entire day, causing fataI injuries, was sentenced
-
Eugene2 days agoEugene Springfield Fire and OSFM host NFPA-certified fire investigation course
